Sanuwave Health, Inc. SNWV

What this company does

Sanuwave is a medical device company providing directed energy products into the wound care space, focused on regenerative medicine utilizing noninvasive ultrasound to produce a biological response promoting the repair and regeneration of tissue, musculoskeletal, and vascular structures. The company's patented and FDA cleared product is the UltraMIST system, which is used to treat a variety of acute and chronic wounds, backed by an intellectual property portfolio of over 60 patents. In the year ended December 31, 2025, the company had total revenues of $44.1 million, a 35% increase from revenues of $32.6 million in the year ended December 31, 2024, with UltraMIST systems and consumables representing approximately 99% of 2025 revenues. The UltraMIST system delivers low frequency, non-thermal ultrasound to target tissues using a fluid mist to transmit energy in a non-contact, pain free fashion, penetrating deep into wound beds to promote healing while reducing inflammation, killing bacteria and biofilms, and increasing the growth of blood vessels in the wound and peri-wound. As of December 31, 2025, the company had a total of 55 full time employees in the United States, of which 15 were engaged in research and development, and none are represented by a labor union or covered by a collective bargaining agreement. The company was formed as a Nevada corporation in 2004, with corporate headquarters at 9600 W. 76th Street, Suite 118, Eden Prairie, MN, 55344.

Written from the business description in SANUWAVE Health, Inc.'s annual report to the U.S. Securities and Exchange Commission, filed 26 March 2026. Every sentence was checked against that document before publication.